Mitochondrial A3243G mutation with manifestation of acute dilated cardiomyopathy.


Autoria(s): Stalder N.; Yarol N.; Tozzi P.; Rotman S.; Morris M.; Fellmann F.; Schwitter J.; Hullin R.
Data(s)

2012

Identificador

http://serval.unil.ch/?id=serval:BIB_6E38D26D6857

isbn:1941-3297 (Electronic)

pmid:22253408

doi:10.1161/CIRCHEARTFAILURE.111.963900

isiid:000299324100001

Idioma(s)

en

Fonte

Circulation. Heart Failure, vol. 5, no. 1, pp. e1-e3

Palavras-Chave #Adrenergic beta-Antagonists/therapeutic use; Adult; Angiotensin-Converting Enzyme Inhibitors/therapeutic use; Cardiomyopathy, Dilated/drug therapy; Cardiomyopathy, Dilated/etiology; DNA, Mitochondrial/genetics; Drug Therapy, Combination; Female; Humans; MELAS Syndrome/complications; MELAS Syndrome/diagnosis; Mineralocorticoid Receptor Antagonists/therapeutic use; Mutation/genetics; Treatment Outcome
Tipo

info:eu-repo/semantics/article

article